• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国社区糖尿病患者数据驱动聚类中的临床特征和并发症风险。

Clinical characteristics and complication risks in data-driven clusters among Chinese community diabetes populations.

机构信息

School of Medicine, Nankai University, Tianjin, China.

Department of Endocrinology, the First medical center of PLA General Hospital, Beijing, China.

出版信息

J Diabetes. 2024 Aug;16(8):e13596. doi: 10.1111/1753-0407.13596.

DOI:10.1111/1753-0407.13596
PMID:39136497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11320751/
Abstract

BACKGROUND

Novel diabetes phenotypes were proposed by the Europeans through cluster analysis, but Chinese community diabetes populations might exhibit different characteristics. This study aims to explore the clinical characteristics of novel diabetes subgroups under data-driven analysis in Chinese community diabetes populations.

METHODS

We used K-means cluster analysis in 6369 newly diagnosed diabetic patients from eight centers of the REACTION (Risk Evaluation of cAncers in Chinese diabeTic Individuals) study. The cluster analysis was performed based on age, body mass index, glycosylated hemoglobin, homeostatic modeled insulin resistance index, and homeostatic modeled pancreatic β-cell functionality index. The clinical features were evaluated with the analysis of variance (ANOVA) and chi-square test. Logistic regression analysis was done to compare chronic kidney disease and cardiovascular disease risks between subgroups.

RESULTS

Overall, 2063 (32.39%), 658 (10.33%), 1769 (27.78%), and 1879 (29.50%) populations were assigned to severe obesity-related and insulin-resistant diabetes (SOIRD), severe insulin-deficient diabetes (SIDD), mild age-associated diabetes mellitus (MARD), and mild insulin-deficient diabetes (MIDD) subgroups, respectively. Individuals in the MIDD subgroup had a low risk burden equivalent to prediabetes, but with reduced insulin secretion. Individuals in the SOIRD subgroup were obese, had insulin resistance, and a high prevalence of fatty liver, tumors, family history of diabetes, and tumors. Individuals in the SIDD subgroup had severe insulin deficiency, the poorest glycemic control, and the highest prevalence of dyslipidemia and diabetic nephropathy. Individuals in MARD subgroup were the oldest, had moderate metabolic dysregulation and the highest risk of cardiovascular disease.

CONCLUSION

The data-driven approach to differentiating the status of new-onset diabetes in the Chinese community was feasible. Patients in different clusters presented different characteristics and risks of complications.

摘要

背景

欧洲人通过聚类分析提出了新型糖尿病表型,但中国社区糖尿病人群可能表现出不同的特征。本研究旨在通过数据驱动分析探讨中国社区糖尿病人群中新发糖尿病亚组的临床特征。

方法

我们使用来自 REACTION(中国糖尿病个体癌症风险评估)研究的 8 个中心的 6369 例新诊断糖尿病患者进行 K-均值聚类分析。聚类分析基于年龄、体重指数、糖化血红蛋白、稳态模型胰岛素抵抗指数和稳态模型胰岛β细胞功能指数。采用方差分析(ANOVA)和卡方检验对临床特征进行评估。进行逻辑回归分析以比较亚组之间慢性肾脏病和心血管疾病的风险。

结果

总体而言,2063(32.39%)、658(10.33%)、1769(27.78%)和 1879(29.50%)人群分别被分配到严重肥胖相关和胰岛素抵抗性糖尿病(SOIRD)、严重胰岛素缺乏性糖尿病(SIDD)、轻度年龄相关性糖尿病(MARD)和轻度胰岛素缺乏性糖尿病(MIDD)亚组。MIDD 亚组的个体风险负担相当于糖尿病前期,但胰岛素分泌减少。SOIRD 亚组的个体肥胖、存在胰岛素抵抗以及脂肪肝、肿瘤、糖尿病家族史和肿瘤的患病率较高。SIDD 亚组的个体存在严重的胰岛素缺乏、血糖控制最差以及血脂异常和糖尿病肾病的患病率最高。MARD 亚组的个体年龄最大、代谢失调最严重且心血管疾病风险最高。

结论

通过数据驱动的方法对中国社区新发糖尿病的状态进行分类是可行的。不同亚组的患者表现出不同的特征和并发症风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f924/11320751/31507134d52c/JDB-16-e13596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f924/11320751/adcdcea4e8ca/JDB-16-e13596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f924/11320751/31507134d52c/JDB-16-e13596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f924/11320751/adcdcea4e8ca/JDB-16-e13596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f924/11320751/31507134d52c/JDB-16-e13596-g002.jpg

相似文献

1
Clinical characteristics and complication risks in data-driven clusters among Chinese community diabetes populations.中国社区糖尿病患者数据驱动聚类中的临床特征和并发症风险。
J Diabetes. 2024 Aug;16(8):e13596. doi: 10.1111/1753-0407.13596.
2
Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study.中年和老年中国人的新型糖尿病亚组和慢性并发症:一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2022 Jan 26;12:802114. doi: 10.3389/fendo.2021.802114. eCollection 2021.
3
Clinical application of cluster analysis in patients with newly diagnosed type 2 diabetes.聚类分析在新诊断2型糖尿病患者中的临床应用
Hormones (Athens). 2025 Mar;24(1):109-122. doi: 10.1007/s42000-024-00593-4. Epub 2024 Sep 4.
4
Identification of two novel subgroups in patients with diabetes mellitus and their association with clinical outcomes: A two-step cluster analysis.两步聚类分析鉴定糖尿病患者的两个新亚组及其与临床结局的关系。
J Diabetes Investig. 2021 Aug;12(8):1346-1358. doi: 10.1111/jdi.13494. Epub 2021 Feb 14.
5
Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.近期诊断糖尿病患者亚组中糖尿病相关疾病的风险:一项为期 5 年的随访研究。
Lancet Diabetes Endocrinol. 2019 Sep;7(9):684-694. doi: 10.1016/S2213-8587(19)30187-1. Epub 2019 Jul 22.
6
Validation of the Swedish Diabetes Re-Grouping Scheme in Adult-Onset Diabetes in China.瑞典糖尿病重新分组方案在中国成人发病型糖尿病中的验证
J Clin Endocrinol Metab. 2020 Oct 1;105(10). doi: 10.1210/clinem/dgaa524.
7
Clinical Characteristics and Risk of Diabetic Complications in Data-Driven Clusters Among Type 2 Diabetes.数据驱动聚类分析 2 型糖尿病患者的临床特征及糖尿病并发症风险
Front Endocrinol (Lausanne). 2021 Jun 30;12:617628. doi: 10.3389/fendo.2021.617628. eCollection 2021.
8
Cardiorenal Risk Profiles Among Data-Driven Type 2 Diabetes Sub-Phenotypes: A Analysis of the China Health and Nutrition Survey.基于数据驱动的 2 型糖尿病亚型的心脏肾脏风险特征:对中国健康与营养调查的分析。
Front Endocrinol (Lausanne). 2022 Apr 6;13:828403. doi: 10.3389/fendo.2022.828403. eCollection 2022.
9
Are the Different Diabetes Subgroups Correlated With All-Cause, Cancer-Related, and Cardiovascular-Related Mortality?不同的糖尿病亚组与全因、癌症相关和心血管相关死亡率相关吗?
J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa628.
10
Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study.2型糖尿病的新型亚组及其与亚洲印度人群微血管结局的关联:一项数据驱动的聚类分析:INSPIRED研究
BMJ Open Diabetes Res Care. 2020 Aug;8(1). doi: 10.1136/bmjdrc-2020-001506.

引用本文的文献

1
Heterogeneity of diabetes and disease progression with a tree-like representation: findings from the China Cardiometabolic Disease and Cancer Cohort (4C) study.糖尿病的异质性与疾病进展的树状表示:中国心血管代谢疾病与癌症队列(4C)研究的结果
Diabetologia. 2025 Aug 30. doi: 10.1007/s00125-025-06528-x.
2
Cluster Analysis in Diabetes Research: A Systematic Review Enhanced by a Cross-Sectional Study.糖尿病研究中的聚类分析:一项横断面研究增强的系统评价
J Clin Med. 2025 May 21;14(10):3588. doi: 10.3390/jcm14103588.
3
Young-onset type 2 diabetes-Epidemiology, pathophysiology, and management.

本文引用的文献

1
Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition.印度糖尿病患病率:IDF 糖尿病地图集第 10 版综述。
Curr Diabetes Rev. 2024;20(1):e130423215752. doi: 10.2174/1573399819666230413094200.
2
Clinical Characteristics of Inpatients With New-Onset Diabetes Mellitus in Eastern China: Based on Novel Clustering Analysis.基于新型聚类分析的中国东部新发糖尿病住院患者的临床特征。
Front Endocrinol (Lausanne). 2022 Jul 27;13:927661. doi: 10.3389/fendo.2022.927661. eCollection 2022.
3
Adaptive Box-Cox Transformation: A Highly Flexible Feature-Specific Data Transformation to Improve Metabolomic Data Normality for Better Statistical Analysis.
青年发病型2型糖尿病——流行病学、病理生理学及管理
J Diabetes Investig. 2025 Jul;16(7):1157-1172. doi: 10.1111/jdi.70081. Epub 2025 May 24.
4
Application of the C-reactive protein-triglyceride glucose index in predicting the risk of new-onset diabetes in the general population aged 45 years and older: a national prospective cohort study.C反应蛋白-甘油三酯血糖指数在预测45岁及以上普通人群新发糖尿病风险中的应用:一项全国性前瞻性队列研究。
BMC Endocr Disord. 2025 May 9;25(1):126. doi: 10.1186/s12902-025-01947-8.
5
Recent updates to understand the heterogeneity of type 2 diabetes mellitus.了解2型糖尿病异质性的最新进展。
J Diabetes Investig. 2025 Apr;16(4):578-580. doi: 10.1111/jdi.70001. Epub 2025 Feb 1.
自适应 Box-Cox 变换:一种高度灵活的特征特定数据变换方法,用于改善代谢组学数据正态性,从而实现更好的统计分析。
Anal Chem. 2022 Jun 14;94(23):8267-8276. doi: 10.1021/acs.analchem.2c00503. Epub 2022 Jun 3.
4
Identification and epidemiological characterization of Type-2 diabetes sub-population using an unsupervised machine learning approach.采用无监督机器学习方法鉴定和流行病学特征分析 2 型糖尿病亚人群。
Nutr Diabetes. 2022 May 27;12(1):27. doi: 10.1038/s41387-022-00206-2.
5
Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications.2 型糖尿病的新型亚组表现出不同的表观遗传模式,这些模式与未来的糖尿病并发症相关。
Diabetes Care. 2022 Jul 7;45(7):1621-1630. doi: 10.2337/dc21-2489.
6
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations.中国和印度人群 2 型糖尿病的病理生理学、表型和管理。
Nat Rev Endocrinol. 2022 Jul;18(7):413-432. doi: 10.1038/s41574-022-00669-4. Epub 2022 May 4.
7
Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study.2 型糖尿病发病年龄与心血管疾病及死亡率的关系:开滦研究。
Diabetes Care. 2021 Jun 1;44(6):1426-1432. doi: 10.2337/dc20-2375.
8
Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study.中年和老年中国人的新型糖尿病亚组和慢性并发症:一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2022 Jan 26;12:802114. doi: 10.3389/fendo.2021.802114. eCollection 2021.
9
[Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)].《中国老年2型糖尿病防治临床指南(2022年版)》
Zhonghua Nei Ke Za Zhi. 2022 Jan 1;61(1):12-50. doi: 10.3760/cma.j.cn112138-20211027-00751.
10
Obesity, Diabetes, and Increased Cancer Progression.肥胖、糖尿病与癌症恶化。
Diabetes Metab J. 2021 Nov;45(6):799-812. doi: 10.4093/dmj.2021.0077. Epub 2021 Nov 22.